Mesoblast (MESO) News Today $10.04 -1.28 (-11.31%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsFinancialsHeadlinesOptions ChainOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Mesoblast Limited’s AGM Resolutions Gain Strong ApprovalNovember 16 at 4:17 AM | markets.businessinsider.comMesoblast (NASDAQ:MESO) Shares Gap Down - Should You Sell?Mesoblast (NASDAQ:MESO) Shares Gap Down - Should You Sell?November 15 at 12:19 PM | marketbeat.comMesoblast Limited Advances in Drug Development and CommercializationNovember 15 at 2:41 AM | markets.businessinsider.comMesoblast Limited Outlines Future Strategies and Growth ProspectsNovember 15 at 2:41 AM | markets.businessinsider.comMesoblast (NASDAQ:MESO) Hits New 52-Week High - What's Next?Mesoblast (NASDAQ:MESO) Reaches New 52-Week High - Here's WhyNovember 13, 2024 | marketbeat.comBuy Rating for Mesoblast Driven by Promising Market Opportunities and Upcoming PDUFA Date for RyoncilNovember 8, 2024 | markets.businessinsider.comMesoblast (NASDAQ:MESO) Stock Price Down 3.7% - Should You Sell?Mesoblast (NASDAQ:MESO) Shares Down 3.7% - What's Next?November 1, 2024 | marketbeat.comHealth Check: PharmX has 99pc share of pharmacy market but reckons it has prescription for growthOctober 31, 2024 | msn.comAppendix 4C Quarterly Activity Report for Quarter Ended September 30, 2024October 30, 2024 | globenewswire.comMesoblast (NASDAQ:MESO) Shares Gap Down - Time to Sell?Mesoblast (NASDAQ:MESO) Shares Gap Down - Here's What HappenedOctober 24, 2024 | marketbeat.comMesoblast Advances Cellular Medicines Amid FDA HopesOctober 19, 2024 | finance.yahoo.comMesoblast (NASDAQ:MESO) Shares Gap Up - Here's What HappenedMesoblast (NASDAQ:MESO) Shares Gap Up - Should You Buy?October 17, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Trading Down 2.4% - Here's WhyMesoblast (NASDAQ:MESO) Trading Down 2.4% - Should You Sell?October 16, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Shares Gap Up - Here's WhyMesoblast (NASDAQ:MESO) Shares Gap Up - What's Next?October 11, 2024 | marketbeat.comWhy Block, Cettire, Mesoblast, and Regis Resources shares are rising todayOctober 10, 2024 | msn.comMarshall Wace LLP Invests $562,000 in Mesoblast Limited (NASDAQ:MESO)Marshall Wace LLP purchased a new stake in shares of Mesoblast Limited (NASDAQ:MESO - Free Report) in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm purchased 82,576 shares of the company's stock, valued at apOctober 10, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Stock Price Down 3.5% - Here's What HappenedMesoblast (NASDAQ:MESO) Stock Price Down 3.5% - Here's What HappenedOctober 9, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Stock Quotes, Forecast and News SummaryOctober 4, 2024 | benzinga.comWhy Insignia, Light & Wonder, Mesoblast, and Woodside shares are racing higher todayOctober 4, 2024 | msn.comMesoblast (NASDAQ:MESO) Shares Gap Up to $8.76Mesoblast (NASDAQ:MESO) Shares Gap Up to $8.76October 3, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Reaches New 52-Week High at $8.70Mesoblast (NASDAQ:MESO) Reaches New 52-Week High at $8.70October 2, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Trading Up 7.9%Mesoblast (NASDAQ:MESO) Stock Price Up 7.9%September 30, 2024 | marketbeat.comSignal No. 4 up in Batanes, Babuyan Island as Typhoon Julian whips northern LuzonSeptember 30, 2024 | msn.comShort Interest in Mesoblast Limited (NASDAQ:MESO) Rises By 20.5%Mesoblast Limited (NASDAQ:MESO - Get Free Report) was the target of a large growth in short interest during the month of September. As of September 15th, there was short interest totalling 1,010,000 shares, a growth of 20.5% from the August 31st total of 838,200 shares. Based on an average daily volume of 157,200 shares, the short-interest ratio is presently 6.4 days.September 30, 2024 | marketbeat.comMesoblast Option to Issue Up to US$50 Million Convertible Notes for Product LaunchSeptember 29, 2024 | globenewswire.comDr. Roach: Med for Crohn’s disease needs to be changed due to melanomaSeptember 25, 2024 | detroitnews.comMesoblast (NASDAQ:MESO) Stock Rating Upgraded by Maxim GroupMaxim Group raised shares of Mesoblast from a "hold" rating to a "buy" rating and set a $12.00 price target for the company in a report on Tuesday.September 24, 2024 | marketbeat.comMESO Jan 2025 2.000 callSeptember 21, 2024 | ca.finance.yahoo.comMesoblast (NASDAQ:MESO) Trading Up 6.4%Mesoblast (NASDAQ:MESO) Trading 6.4% HigherSeptember 20, 2024 | marketbeat.comMesoblast (MESO): Biotechnology Innovator Nearing Critical Milestones for Life-Changing TherapiesSeptember 19, 2024 | msn.comPet Stem Cells Market Set to Reach $550 Million by 2030 | Exactitude ConsultancySeptember 19, 2024 | finance.yahoo.comMoldovan central bank keeps key rate unchanged at 3.60%September 19, 2024 | ca.finance.yahoo.comMesoblast (NASDAQ:MESO) Shares Gap Up to $6.22Mesoblast (NASDAQ:MESO) Shares Gap Up to $6.22September 16, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Shares Down 3.1% Mesoblast (NASDAQ:MESO) Stock Price Down 3.1%September 13, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Shares Pass Below 50 Day Moving Average of $6.80Mesoblast (NASDAQ:MESO) Share Price Crosses Below 50 Day Moving Average of $6.80September 12, 2024 | marketbeat.comSkye Bioscience (SKYE) Gets a Buy from Piper SandlerSeptember 10, 2024 | markets.businessinsider.comMesoblast (NASDAQ:MESO) Trading Down 4%Mesoblast (NASDAQ:MESO) Stock Price Down 4%September 4, 2024 | marketbeat.comMesoblast (NASDAQ:MESO) Cut to "Sell" at StockNews.comStockNews.com downgraded Mesoblast from a "hold" rating to a "sell" rating in a research report on Wednesday.September 4, 2024 | marketbeat.comMesoblast Limited (NASDAQ:MESO) Q4 2024 Earnings Call TranscriptSeptember 4, 2024 | msn.comIs Mesoblast (MESO) The Best Australian Stock To Buy According to Hedge Funds?September 3, 2024 | msn.comMesoblast (NASDAQ:MESO) Shares Gap Up to $6.47Mesoblast (NASDAQ:MESO) Shares Gap Up to $6.47August 30, 2024 | marketbeat.comMesoblast (MESO) Receives a Buy from Piper SandlerAugust 30, 2024 | markets.businessinsider.comMesoblast Limited (MESO) Q4 2024 Earnings Call TranscriptAugust 29, 2024 | seekingalpha.comMesoblast share price slumps as FY24 earnings fail to impressAugust 29, 2024 | msn.comMesoblast Limited 2024 Q4 - Results - Earnings Call PresentationAugust 28, 2024 | seekingalpha.comMesoblast Reports Financial Results and Operational Update for Fiscal Year Ended June 30, 2024August 28, 2024 | globenewswire.comMesoblast FY Earnings PreviewAugust 27, 2024 | msn.comMesoblast Financial Results and Corporate Update WebcastAugust 27, 2024 | globenewswire.comMesoblast (NASDAQ:MESO) Upgraded to Hold by StockNews.comStockNews.com upgraded Mesoblast from a "sell" rating to a "hold" rating in a research note on Tuesday.August 27, 2024 | marketbeat.com2 ASX healthcare shares outperforming peers on positive company newsAugust 22, 2024 | msn.com Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MESO and its competitors with MarketBeat's FREE daily newsletter. Email Address There is a little known company that is changing warfare (Ad)With geo - political instability around the world investors are flocking to defense contract stocks. There is a little known company that is changing warfare. With the backing of U.S. government contracts, this startup is reshaping the future of the U.S. military. Click here to gain instant access to one of the most exclusive pre-ipo opportunities in the market t MESO Media Mentions By Week MESO Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MESO News Sentiment▼0.800.55▲Average Medical News Sentiment MESO News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MESO Articles This Week▼63▲MESO Articles Average Week Get Mesoblast News Delivered to You Automatically Sign up to receive the latest news and ratings for MESO and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies TGTX News Today IBRX News Today BHC News Today MRUS News Today RYTM News Today APLS News Today EWTX News Today XENE News Today IOVA News Today HCM News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:MESO) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | SponsoredThe pin that pops the AI bubbleMy new documentary explores the background to this pattern and how and why I believe it will almost certainly ...Porter & Company | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredTrump’s IRS Hands Massive ‘Victory Gift’ To 401K OwnersThe "Fake Media" has completely ignored Trump's genius "victory gift" to all America First patriots like you. ...Colonial Metals | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Mesoblast Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Mesoblast With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MESO Stock Alerts